| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |